SPI Healthcare
|
3 597,97
|
5,14
|
0,14%
|
Analysen zu SPI Healthcare-Werten
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Underweight | Barclays Capital | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.11.24 | Novartis Buy | UBS AG | |
| 20.11.24 | Roche Hold | Jefferies & Company Inc. | |
| 20.11.24 | Novartis Hold | Deutsche Bank AG | |
| 19.11.24 | Roche Sell | Deutsche Bank AG | |
| 14.11.24 | Novartis Buy | UBS AG | |
| 13.11.24 | Roche Neutral | UBS AG | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | Roche Neutral | UBS AG | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Outperform | Bernstein Research | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.10.24 | Roche Kaufen | DZ BANK | |
| 24.10.24 | Roche Sell | Deutsche Bank AG | |
| 23.10.24 | Roche Neutral | UBS AG | |
| 23.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.10.24 | Roche Hold | Jefferies & Company Inc. | |
| 18.10.24 | Roche Sell | Deutsche Bank AG | |
| 14.10.24 | Roche Sell | Deutsche Bank AG | |
| 14.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 08.10.24 | Novartis Hold | Deutsche Bank AG | |
| 03.10.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.10.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 19.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Neutral | UBS AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.